Summary. HLA phenotypes were studied in 57 Type 2 (noninsulin-dependent) diabetic Papuan patients and the results compared with control subjects of the same Austronesian origin. An association was found between disease and BW62, a split antigen of B15, with corrected probability significant at the 5% level. The frequencies of B13 and BW22 were also increased in diabetic patients but the differences were not statistically significant. Although it has been postulated that Melanesian communities have protection against diabetes, they have a high frequency of BW62, which would imply, from the association found in this study, that susceptibility to Type 2 diabetes has yet to become manifest in them.
Type 2 (non-insulin-dependent) diabetes mellitus is emerging as a concern to public health in the urban centres of Papua New Guinea [1] [2] [3] . This increase in prevalence is attributed largely to the rapid socio-economic changes and the adoption of a Westernised life-style which unmasks the underlying genetic predisposition to the disease as is seen in the other Pacific nations [1, 4] .
Family and twin studies have established that Type 2 diabetes has a stronger genetic component than Type I (insulin-dependent) diabetes [5] , but the precise definition of the major genes responsible for the former has been more difficult to establish. This problem is accentuated by the failure to detect an association between Type 2 diabetes and histocompatibility antigens (HLA) in most population groups [6, 7] . However, HLA studies on selected ethnic groups have shown a small but consistent risk for developing Type 2 diabetes associated with antigens of HLA-A and -B loci [8] [9] [10] [11] [12] [13] . These observations indicate that a careful analysis of such an association in different ethnic groups may provide clues relating to the genetics of this form of diabetes [12] .
We have studied the association of Type 2 diabetes with antigens of HLA-A and -B loci in diabetic patients from the Papuan (southern) coast of Papua New Guinea.
Subjects and methods

Subjects
Fifty-seven patients were selected for the study from patients attending the diabetic clinic at Port Moresby General Hospital. Most of the patients originated from the Marshall Lagoon and Rigo areas of Central Province. The other large group included in the study was from Hanuabada and Pari villages within the Port Moresby area, also in Central Province. Three subjects each were from Kerema in Gulf Province and Samarai in Milne Bay Province. All of the patients were therefore from the Papuan region and spoke Motu or another closelyrelated Austronesian language.
The diagnosis of diabetes was based on the criteria recommended by the WHO Expert Committee on Diabetes [14] . At the time of presentation, all the patients had diabetes with symptoms or signs related to the complications of the disease. None was ketosis-prone and most were obese (33 out of 57). The mean age at onset of diabetes was and varied between 6 months to 20 years. Twenty-two patients had microvascular complications (retinopathy or significant proteinuria), one had suffered a myocardial infarct, another had had a foot amputated due to atheroma, while one patient had a hemiplegia due to cerebral infarction. Twenty-seven patients had been admitted to hospital on one or more occasions for severe infections.
Methods
Heparinised blood (30 ml) was collected from each patient in Port Moresby and air-freighted at room temperature on the same day to Goroka. Mononuclear cells were separated within 24 h of blood collection by flotation on Ficoll-Isopaque. The procedures used for the separation of T lymphocytes and the typing of HLA-A and -B locus antigens are given by Bhatia et al. [15] .
Statistical analysis
Frequencies of HLA antisera in patients were compared with those in two control populations from the same geographical area reported by Ting et al. [16] . The significance of association of individual HLA antigens with Type 2 diabetes was tested by 2 • 2 Z 2 contingency comparisons. The significance level of probability of each chi-square value was corrected for the number of antigens recovered in the sample at the locus in question. The relative risk of developing the disease for a particular antigen was obtained by the odds ratio. Gene frequencies were calculated by using both the square root and the gene counting methods.
Results
The antigen and gene frequencies for HLA-A and -B loci in all diabetic patients are shown in Table 1 . The two major groups of patients included in the study, one from the Marshall Lagoon and Rigo areas and the other from the Hanuabada and Pari villages in Port Moresby area, showed no significant differences from each other for antigen frequencies at either HLA-A or -B loci; consequently, the data were pooled for comparison with the controls. The estimates of gene frequencies obtained from the two methods showed no differences from each other, thus indicating the relative lack of unidentified antigens in this study.
Comparison of the frequencies of HLA antigens between diabetic and control groups revealed similar distributions with no significant differences at the HLA-A locus. However, a number of antigens at the HLA-B locus (B13, BW22 and B15) showed increased frequencies in diabetic patients (Table 2 ) with no concomitant significant decreases in frequencies of other HLA antigens. Of these, B13 and BW22 showed an increase which was not significant. Only BW62 (a split antigen of B15) showed differences from the two controls which were significant at the 5% level of corrected probability.
Discussion
This report of an increased association of BW62 with Type 2 diabetes in coastal Papuans supports the suggestion by Serjeantson et al. of minor MHC influences in Type 2 diabetes in non-European populations [12] . This has been shown to occur for HLA-A2 among Pima Indians [10] and among the Xhosa of South Africa [9] , and for HLA-BW61 among Asian Indians who have migrated to Fiji [12] .
The HLA studies of Serjeantson et al. in diabetic patients from other Pacific islands are relevant to our findings. Nauruans who develop diabetes before the age of 46 years have a significantly decreased frequency of BW62 [8] , but this antigen is not clearly implicated in diabetic patients from four other Pacific islands although the frequency of B15 (BW62) is increased in diabetics in Melanesian populations [13, present study] . Recently, Serjeantson et al. [17] have reported two variants of BW62 in Melanesians from New Caledonia, and it is likely that such heterogeneity may have affected the significance of earlier results.
In Micronesians [8] and Polynesians [13] , Serjeantson and her co-workers have found significantly increased risks for the development of Type 2 diabetes in the presence of BW22. Similar, though non-significant, increases were found in Melanesians from Fiji, New Caledonia and Loyalty Islands [13] . In the light of Serjeantson's findings, the increase in the frequency of BW22 in Papuans reported in this study indicates that this antigen is associated with a real but small increase in risk for Type 2 diabetes in the Pacific.
In our sample of diabetic patients, the frequency of unidentified alleles was found to be low. In contrast, the frequency of blank alleles in the control population, investigated by Ting et al. [16] , was about 20%. We have compared the antigen frequencies of HLA-A and -B loci studied by our group with those reported by other investigators for a number of New Guinean populations [15, K.Bhatia and M.Gorogo, unpublished observations]. No significant differences in antigen frequencies, specially in those of B13, BW22 and B15 (BW62), were noticed. It is, therefore, unlikely that the differences in antigen frequencies of B15 (BW62) and BW22 between the diabetic patients and control groups can be explained by the incomplete definition of Melanesian antigens in 1970's.
Melanesian populations reported to have a high prevalence of Type 2 diabetes in Fiji [18] , New Caledonia [18] , Torres Strait Islands [19] , New Britain [2] and in urban Papua [1] , are all of Austronesian origin. Diabetes does not occur at present in non-Austronesian populations of highland Papua New Guinea [20] . However, one disturbing fact is that the antigen frequency of BW62 in highlanders is more than 40% [15] . Most of the highland populations have been exposed to a modern life-style for a relatively short period and if the Type 2 diabetes-HLA associations have any prognostic implications, the increasing modernisation of these traditional societies is cause for concern. Longitudinal studies are in progress at the Papua New Guinea Institute of Medical Research to monitor glucose intolerance in these highland communities.
